PharmaCielo (TSXV:PCLO) Stock Based Compensation : C$2.38 Mil (TTM As of Sep. 2023)

View and export this data going back to 2018. Start your Free Trial

What is PharmaCielo Stock Based Compensation?

PharmaCielo's Stock Based Compensation for the three months ended in Sep. 2023 was C$0.48 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Sep. 2023 was C$2.38 Mil.

PharmaCielo Stock Based Compensation Historical Data

The historical data trend for PharmaCielo's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaCielo Stock Based Compensation Chart

PharmaCielo Annual Data

Trend

Aug17

Aug18

Dec19

Dec20

Dec21

Dec22

Stock Based Compensation

Get a 7-Day Free Trial

0.04

11.31

6.48

6.82

2.21

PharmaCielo Quarterly Data
	Nov18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Stock Based Compensation	Get a 7-Day Free Trial															0.67	0.60	0.80	0.50	0.48

PharmaCielo Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$2.38 Mil.

PharmaCielo Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of PharmaCielo's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaCielo (TSXV:PCLO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PharmaCielo Ltd (TSXV:PCLO) » Definitions » Stock Based Compensation

Comparable Companies

Traded in Other Exchanges

PCLOF:USA

Address

82 Richmond Street East, Toronto, ON, CAN, M5C 1P1

Website

https://www.pharmacielo.com

PharmaCielo Ltd is a pharma company, with a focus on ethical and sustainable processing and supplying of both THC(tetrahydrocannabinol) and CBD (cannabidiol) medicinal cannabis extracts. The company operates in Canada, Colombia, Italy, and Mexico. It generates the majority of the revenue in the form of the Sale of Cannabis derivative products in Colombia.

Executives

Ian D Atacan

Director, Senior Officer

PharmaCielo (TSXV:PCLO) Headlines

No Headlines